Whitehawk Therapeutics (WHWK) Revenue (2018 - 2025)

Whitehawk Therapeutics (WHWK) has 7 years of Revenue data on file, last reported at $7.1 million in Q1 2025.

• On a quarterly basis, Revenue rose 33.48% year-over-year to $7.1 million in Q1 2025; TTM through Dec 2025 was $7.1 million, a 72.5% decrease from a year earlier, with the FY2025 full-year figure at $7.1 million, down 72.5% from the prior year.
• Revenue for Q1 2025 stood at $7.1 million, down from $7.2 million in the prior quarter.
• Over the last five years, Revenue for WHWK reached as high as $14.0 million in Q4 2021 and fell as low as $120000.0 in Q1 2021.
• Historically, Revenue has averaged $5.8 million across 5 years, with a median of $6.0 million in 2023.
• On a YoY basis, Revenue climbed as much as 1822.5% in 2022 and fell as far as 62.66% in 2022.
• Year by year, Revenue stood at $14.0 million in 2021, then sank by 62.66% to $5.2 million in 2022, then advanced by 21.03% to $6.3 million in 2023, then grew by 14.43% to $7.2 million in 2024, then declined by 1.3% to $7.1 million in 2025.
• Per Business Quant data, the three most recent Revenue figures were $7.1 million in Q1 2025, $7.2 million in Q4 2024, and $7.2 million in Q3 2024.